A Compassionate Use (CU) Program of Odronextamab
- Conditions
- Relapsed or Refractory (R/R) Follicular Lymphoma (FL)Diffuse Large B-Cell Lymphoma (DLBCL)B-Cell Non-Hodgkin Lymphoma (NHL)High-Grade B-Cell Lymphoma (HGBCL)
- Registration Number
- NCT05619367
- Lead Sponsor
- Regeneron Pharmaceuticals
- Brief Summary
Provide compassionate use of odronextamab
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- AVAILABLE
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- EXPANDED_ACCESS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method